You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 18, 2024

PEPCID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pepcid patents expire, and what generic alternatives are available?

Pepcid is a drug marketed by Salix Pharms, Merck, Bausch, J And J Consumer Inc, and Merck Sharp Dohme. and is included in nine NDAs.

The generic ingredient in PEPCID is calcium carbonate; famotidine; magnesium hydroxide. There are two hundred and eighty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the calcium carbonate; famotidine; magnesium hydroxide profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PEPCID?
  • What are the global sales for PEPCID?
  • What is Average Wholesale Price for PEPCID?
Drug patent expirations by year for PEPCID
Drug Prices for PEPCID

See drug prices for PEPCID

Recent Clinical Trials for PEPCID

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ohio State University Comprehensive Cancer CenterPhase 2/Phase 3
Leidos Life SciencesPhase 2
United States Department of DefensePhase 2

See all PEPCID clinical trials

US Patents and Regulatory Information for PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020325-001 Apr 28, 1995 OTC Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bausch PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Merck Sharp Dohme PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER famotidine INJECTABLE;INJECTION 020249-001 Feb 18, 1994 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 OTC No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PEPCID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Salix Pharms PEPCID famotidine FOR SUSPENSION;ORAL 019527-001 Feb 2, 1987 ⤷  Sign Up ⤷  Sign Up
Bausch PEPCID famotidine TABLET;ORAL 019462-001 Oct 15, 1986 ⤷  Sign Up ⤷  Sign Up
Bausch PEPCID famotidine TABLET;ORAL 019462-002 Oct 15, 1986 ⤷  Sign Up ⤷  Sign Up
Merck PEPCID famotidine INJECTABLE;INJECTION 019510-001 Nov 4, 1986 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PEPCID

See the table below for patents covering PEPCID around the world.

Country Patent Number Title Estimated Expiration
Slovenia 8010622 PROCESS FOR PREPARATION OF GUANIDINE THIAZOLE COMPOUNDS ⤷  Sign Up
Denmark 93580 ⤷  Sign Up
Spain 8100281 ⤷  Sign Up
Switzerland 644114 GUANIDINOTHIAZOLVERBINDUNGEN, VERFAHREN ZU IHRER HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL. ⤷  Sign Up
Yugoslavia 42966 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.